VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial

BACKGROUND: The probiotic mixture VSL#3 has proven efficacious in inflammatory bowel diseases and irritable bowel syndrome; however, its efficacy in microscopic colitis (MC) is being investigated. OBJECTIVE: To evaluate the safety and efficacy of a multistrain probiotic, VSL#3, in inducing clinical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Open Gastroenterol
Autores principales: Rohatgi, Sarika, Ahuja, Vineet, Makharia, Govind K, Rai, Tarun, Das, Prasenjit, Dattagupta, Siddharth, Mishra, Veena, Garg, Sushil Kumar
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2015
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599154/
https://ncbi.nlm.nih.gov/pubmed/26462271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000018
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares